Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | IM |
Patient received only one dose of Rabavert, did not complete the rest of the series; Case reference number US-BN-2024-001946 is a spontaneous case report initially received from a nurse via Med Communication (reference number: USBAV24-1144) on 24-May-2024 and concerns a male patient of unknown age. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient had dog bite. On 17-May-2024, unknown amount of time after the dog bite, the patient was vaccinated with the first dose of RabAvert (batch number: unknown) intramuscularly, at an unknown dose, at unknown site of administration for rabies post exposure prophylaxis in unvaccinated individual. As reported, the patient received only one dose of RabAvert, did not complete the rest of the series (explicitly coded as 'Inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Rabavert. No further information was provided.; Reporter's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert, intramuscularly, at an unknown dose, at unknown site of administration for rabies post exposure prophylaxis in unvaccinated individual.Reportedly, the patient received only one dose of RabAvert and did not complete the rest of the series which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Rabavert. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert, intramuscularly, at an unknown dose, at unknown site of administration for rabies post exposure prophylaxis in unvaccinated individual.Reportedly, the patient received only one dose of RabAvert and did not complete the rest of the series which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Rabavert. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None.